bpc-157 protocol duration clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC 157: Science-Backed Uses, Benefits,
Description
It was proposed that IVD degeneration leads to elevation of CSF1 in the DRG, activating microglia in the spinal cord
Please book an appointment with us to determine the best vitamin injection plan for your needs and start your journey toward improved health and Wellness
Lost 12 pounds in the first two months
They can also be used as a maintenance product once your pigmentation has returned
None of these are required
